Rosalyn Carson-DeWitt, MD
Amyotrophic lateral sclerosis (ALS) is a progressive nervous system disorder. It gradually destroys the nerves responsible for muscle movement. Over time, ALS leads to almost total paralysis of muscle movement, including breathing. Eventually, the disorder leads to respiratory failure.
The cause of ALS is unknown. Genes may play a role.
Factors that may increase your risk of getting ALS include:
Symptoms of ALS include:
You will be asked about your symptoms and medical history. A physical exam will be done. There are no tests that can diagnose ALS. Tests may be used to rule out other medical conditions.
Images may be taken of your bodily structures. This can be done with:
Your bodily fluids and tissues may be tested. This can be done with:
Your muscles and nerves may be evaluated. This can be done with
(EMG)/nerve conduction velocities (NCV).
Your cognitive skills may be assessed. This can be done with neuropsychological testing.
There is currently no cure for ALS.
Treatment may help to reduce or manage symptoms.
A combination of treatments may work best. This may include:
Treatment options include:
has been approved for ALS. The drug may slightly improve functioning, but it does not stop the disease from progressing.
You may be prescribed these medicines for symptoms:
Supportive care may be needed as ALS progresses, including:
There are no guidelines for preventing ALS because the cause is unknown.
National Institute of Neurological Disorders and Stroke
ALS Society of British Columbia
ALS Society of Canada
Aggarwal, SP, Zinman L, Simpson E, et al. Clinical trial testing lithium in ALS terminates early for futility.
2010; 9(5): 481-488.
Amyotrophic lateral sclerosis. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed. Updated February 4, 2014. Accessed February 12, 2014.
Amyotrophic lateral sclerosis fact sheet.
National Institute of Neurological Disorders and Stroke website. Available at:
http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/detail_amyotrophiclateralsclerosis.htm. Updated February 5, 2014. Accessed February 12, 2014.
FDA approves NeuRx Diaphragm Pacing System. ALS Association website. Available at: http://www.alsa.org/news/archive/fda-approves-neurx-diaphragm.html. Updated September 29, 2011. Accessed February 12, 2014.
NeuRx Diaphragm Pacing System. US Food & Drug Administration website. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm278684.htm. Updated September 6, 2013. Accessed February 12, 2014.
Sathasivam S. Managing patients with amyotrophic lateral sclerosis.
Eur J Intern Med.
Walling AD. Amyotrophic lateral sclerosis: Lou Gehrig's disease.
Am Fam Physician. 1999;59:1489-1496.
4/17/2008 DynaMed Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Fornai F, Longone P, Cafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis.
Proc Natl Acad Sci USA. 2008;105:2052-2057.
1/14/2011 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Mateen FJ, Carone M, Sorenson EJ.
Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004.
J Neurol Neurosurg Psychiatry.
Last reviewed February 2014 by Rimas Lukas, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.